| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 1.3K | 0.7% | 5.4% |
| Total Income | 1.3K | 0.7% | 5.4% |
| Expenditure | 1.2K | 1.7% | 6.4% |
| PBT | -3.70 | 104.0% | 104.7% |
| Net Profit | -26.30 | 142.5% | 153.3% |
| OPM | 9.67% | 0.84pp | 0.86pp |
| NPM | -1.98% | 6.68pp | 5.90pp |
| EPS | -0.25 | 141.7% | 152.1% |
Herbalife Reports Q2 2026 Net Sales Growth; CFO Transition Announced
06 Aug 2026 · 6 Aug, 2:02 am
Summary
Herbalife Ltd. announced its financial results for the second fiscal quarter ended June 30, 2026, reporting net sales of $1.3 billion, up 5.4% year-over-year, and marking its fourth consecutive quarter of topline growth. Despite a net loss of $(26.3) million, largely due to a debt extinguishment charge, the company's adjusted EBITDA reached $166.6 million, exceeding guidance on a constant currency basis. Management highlighted the resilience of the business and the successful launch of new personalized nutrition products, while also announcing a planned CFO transition.
Key Highlights
- 1
Herbalife reported second quarter 2026 net sales of $1.3 billion, an increase of 5.4% year-over-year, marking the fourth consecutive quarter of topline expansion.
- 2
On a constant currency basis, net sales increased by 5.8% year-over-year, exceeding guidance.
- 3
The company reported a net loss attributable to Herbalife of $(26.3) million, which includes a $94.6 million loss on extinguishment of debt from an April 2026 refinancing.
- 4
Adjusted EBITDA for the second quarter was $166.6 million, towards the upper end of guidance, and $174.4 million on a constant currency basis, exceeding guidance.
- 5
Adjusted diluted EPS for the quarter was $0.51.
- 6
Herbalife launched its next generation of personalized products with Bioniq GO in eleven EMEA markets and North America.
- 7
The company provided guidance for the third quarter of 2026 and revised its full-year 2026 guidance for net sales and adjusted EBITDA.
Management Comments
John DeSimone
Our net sales and EBITDA results for the second quarter were at the high end of previously issued guidance. While the recent strengthening of the U.S. dollar has resulted in additional foreign exchange headwinds affecting our reported outlook for the back half of the year, our constant currency outlook remains consistent with the expectations we shared last quarter.
Stephan Gratziani
We delivered a fourth consecutive quarter of year-over-year net sales growth, and we continue to expect net sales growth for the remainder of the year. This momentum reflects the resilience of Herbalife and has us poised to successfully carry out our long-term growth strategy. John DeSimone played an impactful role in laying this foundation, and I am grateful to him for his leadership and partnership. I am confident Scott Schaefer’s financial expertise and strategic perspective will help propel us in our next chapter.
Informational and educational content only. Not investment advice.